Thomas Kromann Lund

Chief Phycisian

Rigshospitalet

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Thomas Kromann Lund is a Chief Physician at Rigshospitalet in Denmark. His research focuses on pulmonary health, particularly in the context of chronic obstructive pulmonary disease (COPD), lung transplantation, and the effects of COVID-19 on respiratory function. Recent articles authored by Dr. Lund explore topics ranging from high intensity interval training in COPD patients to the implications of extracellular vesicles in lung donor plasma.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Ronan Berg

Københavns Universitet

DENMARK

View details

Anne-Mette Lebech

Københavns Universitet

DENMARK

View details

Shailesh B Kolekar

Associate professor

University of Copenhagen

DENMARK

View details

Kishor Dhaygude

University of Helsinki

FINLAND

View details

Jens G. Hillingsoe

Head of department

Rigshospitalet

DENMARK

View details

Thomas Hartvig Lindkær Jensen

Københavns Universitet

DENMARK

View details

Jan Christensen

Københavns Universitet

DENMARK

View details

Thomas Litman

Københavns Universitet

DENMARK

View details

Janine Erler

Københavns Universitet

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Kromann Lund

Research Interests

Contact this professor

About

Articles (15)

Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantation

Extracellular vesicles in lung donor plasma

Machine learning identifies remodeling patterns in human lung extracellular matrix

Pulmonary adaptations to 12 weeks of supervised high intensity interval training in COPD

Survival in Patients With Evidence of Pulmonary Thromboembolism on Ventilation-Perfusion SPECT 12 Weeks After Double Lung Transplantation

Maximal respiratory pressure after <scp>COVID</scp>‐19 compared with reference material in healthy adults: A prospective cohort study (The <scp>SECURe</scp> study)

Pulmonary diffusing capacity for carbon monoxide and nitric oxide after COVID‐19: A prospective cohort study (the SECURe study)

Trends in underlying causes of death in allogeneic hematopoietic cell transplant recipients over the last decade

Identification and management of interstitial lung abnormalities.

Anemia in liver transplant recipients: prevalence, severity, risk factors, and survival

Updated Prevalence of Lymphangioleiomyomatosis in Europe

Incidence and severity of SARS-CoV-2 infection in lung transplant recipients in the Omicron era

Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial.

Size matters in telomere biology disorders ‒ expanding phenotypic spectrum in patients with long or short telomeres

Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study

Collaborators (9)

Ronan Berg

Anne-Mette Lebech

Shailesh B Kolekar

Kishor Dhaygude

Jens G. Hillingsoe

Thomas Hartvig Lindkær Jensen

Jan Christensen

Thomas Litman

Janine Erler

Make your next move.